Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1987 Sep;46(9):691–700. doi: 10.1136/ard.46.9.691

Experimental autoimmune arthritis in mice. I. Homologous type II collagen is responsible for self-perpetuating chronic polyarthritis.

M C Boissier 1, X Z Feng 1, A Carlioz 1, R Roudier 1, C Fournier 1
PMCID: PMC1002235  PMID: 3675011

Abstract

Immunisation with heterologous type II collagen (CII) induces arthritis in mice of the DBA/1 strain, which is genetically susceptible to this disease. To develop an experimental model of autoimmunity more adequate for the study of human rheumatoid arthritis (RA), DBA/1 mice were injected with 100 micrograms of native CII that had been purified from mouse xiphoid cartilage. About six weeks later the animals developed a chronic progressive polyarthritis involving the four paws but mainly confined to interphalangeal and metatarsophalangeal joints. The evolution of the disease fluctuated between remissions and exacerbations. The initial lesions assessed by clinical observations were more severe when the disease occurred early than in the case of late onset. Interestingly, the incidence of arthritis was clearly preponderant in males, and, moreover, the few female mice which developed arthritis had mild disease states with lower arthritic scores than the males. Varying levels of autoantibodies against mouse CII were found in the sera of immunised animals, regardless of the development of arthritis. These data indicate that the injection of homologous CII into mice caused a polyarthritis that is clinically closer to the human RA than the disease induced with heterologous CII and therefore will represent a useful tool for the study of the self-perpetuating mechanisms that characterise RA.

Full text

PDF
691

Images in this article

693Image
on p.693
693Image
on p.693
695Image
on p.695

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andriopoulos N. A., Mestecky J., Miller E. J., Bradley E. L. Antibodies to native and denatured collagens in sera of patients with rheumatoid arthritis. Arthritis Rheum. 1976 May-Jun;19(3):613–617. doi: 10.1002/art.1780190314. [DOI] [PubMed] [Google Scholar]
  2. Clague R. B., Shaw M. J., Holt P. J. Incidence of serum antibodies to native type I and type II collagens in patients with inflammatory arthritis. Ann Rheum Dis. 1980 Jun;39(3):201–206. doi: 10.1136/ard.39.3.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Courtenay J. S., Dallman M. J., Dayan A. D., Martin A., Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature. 1980 Feb 14;283(5748):666–668. doi: 10.1038/283666a0. [DOI] [PubMed] [Google Scholar]
  4. Cracchiolo A., 3rd, Michaeli D., Goldberg L. S., Fudenberg H. H. The occurrence of antibodies to collagen in synovial fluids. Clin Immunol Immunopathol. 1975 Mar;3(4):567–574. doi: 10.1016/0090-1229(75)90081-1. [DOI] [PubMed] [Google Scholar]
  5. Englert M., McReynolds R. A., Landes M. J., Oronsky A. L., Kerwar S. S. Pretreatment of rats with anticollagen IgG renders them resistant to active type II collagen arthritis. Cell Immunol. 1985 Jan;90(1):258–266. doi: 10.1016/0008-8749(85)90188-1. [DOI] [PubMed] [Google Scholar]
  6. Griffiths M. M., Eichwald E. J., Martin J. H., Smith C. B., DeWitt C. W. Immunogenetic control of experimental type II collagen-induced arthritis. I. Susceptibility and resistance among inbred strains of rats. Arthritis Rheum. 1981 Jun;24(6):781–789. doi: 10.1002/art.1780240605. [DOI] [PubMed] [Google Scholar]
  7. Hirofuji T., Kakimoto K., Hori H., Nagai Y., Saisho K., Sumiyoshi A., Koga T. Characterization of monoclonal antibody specific for human type II collagen: possible implication in collagen-induced arthritis. Clin Exp Immunol. 1985 Oct;62(1):159–166. [PMC free article] [PubMed] [Google Scholar]
  8. Holmdahl R., Jansson L., Gullberg D., Rubin K., Forsberg P. O., Klareskog L. Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. Clin Exp Immunol. 1985 Dec;62(3):639–646. [PMC free article] [PubMed] [Google Scholar]
  9. Holmdahl R., Jansson L., Larsson E., Rubin K., Klareskog L. Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum. 1986 Jan;29(1):106–113. doi: 10.1002/art.1780290114. [DOI] [PubMed] [Google Scholar]
  10. Holmdahl R., Rubin K., Klareskog L., Larsson E., Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum. 1986 Mar;29(3):400–410. doi: 10.1002/art.1780290314. [DOI] [PubMed] [Google Scholar]
  11. Janossy G., Panayi G., Duke O., Bofill M., Poulter L. W., Goldstein G. Rheumatoid arthritis: a disease of T-lymphocyte/macrophage immunoregulation. Lancet. 1981 Oct 17;2(8251):839–842. doi: 10.1016/s0140-6736(81)91107-7. [DOI] [PubMed] [Google Scholar]
  12. Klareskog L., Forsum U., Scheynius A., Kabelitz D., Wigzell H. Evidence in support of a self-perpetuating HLA-DR-dependent delayed-type cell reaction in rheumatoid arthritis. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3632–3636. doi: 10.1073/pnas.79.11.3632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Menzel J., Steffen C., Kolarz G., Kojer M., Smolen J. Demonstration of anticollagen antibodies in rheumatoid arthritis synovial fluids by 14C-radioimmunoassay. Arthritis Rheum. 1978 Mar;21(2):243–248. doi: 10.1002/art.1780210212. [DOI] [PubMed] [Google Scholar]
  14. Michaeli D., Fudenberg H. H. The incidence and antigenic specificity of antibodies against denatured human collagen in rheumatoid arthritis. Clin Immunol Immunopathol. 1974 Jan;2(2):153–159. doi: 10.1016/0090-1229(74)90035-x. [DOI] [PubMed] [Google Scholar]
  15. Morgan K., Clague R. B., Shaw M. J., Holt P. J. Native type II collagen-induced arthritis in the rat. I. Incidence and humoral response to collagen. Ann Rheum Dis. 1980 Jun;39(3):285–290. doi: 10.1136/ard.39.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. STEFFEN C., TIMPL R. Antigenicity of collagen and its application in the serological investigation of rheumatoid arthritis sera. Int Arch Allergy Appl Immunol. 1963;22:333–349. doi: 10.1159/000229376. [DOI] [PubMed] [Google Scholar]
  18. Smolen J. S., Menzel E. J., Scherak O., Kojer M., Kolarz G., Steffen C., Mayr W. R. Lymphocyte transformation to denatured type I collagen and B lymphocyte alloantigens in rheumatoid arthritis. Arthritis Rheum. 1980 Apr;23(4):424–431. doi: 10.1002/art.1780230405. [DOI] [PubMed] [Google Scholar]
  19. Solinger A. M., Bhatnagar R., Stobo J. D. Cellular, molecular, and genetic characteristics of T cell reactivity to collagen in man. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3877–3881. doi: 10.1073/pnas.78.6.3877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Staines N. A., Hardingham T., Smith M., Henderson B. Collagen-induced arthritis in the rat: modification of immune and arthritic responses by free collagen and immune anti-collagen antiserum. Immunology. 1981 Dec;44(4):737–744. [PMC free article] [PubMed] [Google Scholar]
  21. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med. 1978 Apr 20;298(16):869–871. doi: 10.1056/NEJM197804202981602. [DOI] [PubMed] [Google Scholar]
  22. Stuart J. M., Cremer M. A., Kang A. H., Townes A. S. Collagen-induced arthritis in rats. Evaluation of early immunologic events. Arthritis Rheum. 1979 Dec;22(12):1344–1351. doi: 10.1002/art.1780221205. [DOI] [PubMed] [Google Scholar]
  23. Stuart J. M., Cremer M. A., Townes A. S., Kang A. H. Type II collagen-induced arthritis in rats. Passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J Exp Med. 1982 Jan 1;155(1):1–16. doi: 10.1084/jem.155.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Stuart J. M., Dixon F. J. Serum transfer of collagen-induced arthritis in mice. J Exp Med. 1983 Aug 1;158(2):378–392. doi: 10.1084/jem.158.2.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stuart J. M., Postlethwaite A. E., Townes A. S., Kang A. H. Cell-mediated immunity to collagen and collagen alpha chains in rheumatoid arthritis and other rheumatic diseases. Am J Med. 1980 Jul;69(1):13–18. doi: 10.1016/0002-9343(80)90494-5. [DOI] [PubMed] [Google Scholar]
  26. Stuart J. M., Townes A. S., Kang A. H. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest. 1982 Mar;69(3):673–683. doi: 10.1172/JCI110495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Takagishi K., Kaibara N., Hotokebuchi T., Arita C., Morinaga M., Arai K. Serum transfer of collagen arthritis in congenitally athymic nude rats. J Immunol. 1985 Jun;134(6):3864–3867. [PubMed] [Google Scholar]
  28. Terato K., Hasty K. A., Cremer M. A., Stuart J. M., Townes A. S., Kang A. H. Collagen-induced arthritis in mice. Localization of an arthritogenic determinant to a fragment of the type II collagen molecule. J Exp Med. 1985 Aug 1;162(2):637–646. doi: 10.1084/jem.162.2.637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Trentham D. E., Belli J. A., Anderson R. J., Buckley J. A., Goetzl E. J., David J. R., Austen K. F. Clinical and immunologic effects of fractionated total lymphoid irradiation in refractory rheumatoid arthritis. N Engl J Med. 1981 Oct 22;305(17):976–982. doi: 10.1056/NEJM198110223051703. [DOI] [PubMed] [Google Scholar]
  30. Trentham D. E. Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum. 1982 Aug;25(8):911–916. doi: 10.1002/art.1780250801. [DOI] [PubMed] [Google Scholar]
  31. Trentham D. E., Dynesius R. A., Rocklin R. E., David J. R. Cellular sensitivity to collagen in rheumatoid arthritis. N Engl J Med. 1978 Aug 17;299(7):327–332. doi: 10.1056/NEJM197808172990703. [DOI] [PubMed] [Google Scholar]
  32. Trentham D. E., Kammer G. M., McCune W. J., David J. R. Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis. Arthritis Rheum. 1981 Nov;24(11):1363–1369. doi: 10.1002/art.1780241105. [DOI] [PubMed] [Google Scholar]
  33. Trentham D. E., Townes A. S., Kang A. H. Autoimmunity to type II collagen an experimental model of arthritis. J Exp Med. 1977 Sep 1;146(3):857–868. doi: 10.1084/jem.146.3.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Watson W. C., Townes A. S. Genetic susceptibility to murine collagen II autoimmune arthritis. Proposed relationship to the IgG2 autoantibody subclass response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J Exp Med. 1985 Dec 1;162(6):1878–1891. doi: 10.1084/jem.162.6.1878. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wooley P. H., Luthra H. S., Griffiths M. M., Stuart J. M., Huse A., David C. S. Type II collagen-induced arthritis in mice. IV. Variations in immunogenetic regulation provide evidence for multiple arthritogenic epitopes on the collagen molecule. J Immunol. 1985 Oct;135(4):2443–2451. [PubMed] [Google Scholar]
  36. Wooley P. H., Luthra H. S., Krco C. J., Stuart J. M., David C. S. Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum. 1984 Sep;27(9):1010–1017. doi: 10.1002/art.1780270907. [DOI] [PubMed] [Google Scholar]
  37. Wooley P. H., Luthra H. S., Stuart J. M., David C. S. Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates. J Exp Med. 1981 Sep 1;154(3):688–700. doi: 10.1084/jem.154.3.688. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES